IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results.

Autor: Puco K; Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Fagereng GL; Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Brabrand S; Department of Oncology, Oslo University Hospital, Oslo, Norway., Niehusmann P; Department of Pathology, Oslo University Hospital, Oslo, Norway., Støre Blix E; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Samdal Steinskog ES; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway., Haug Å; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway., Fredvik Torkildsen C; Department of Obstetrics and Gynecology, Stavanger University Hospital, Stavanger, Norway., Oppedal IA; Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway., Meltzer S; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Flobak Å; Department of Oncology, Trondheim University Hospital, Trondheim, Norway., Johansson KAM; Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Bjørge L; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway., Hjortland GO; Department of Oncology, Oslo University Hospital, Oslo, Norway., Dalhaug A; Department of Oncology, Nordland Hospital, Bodø, Norway., Lund JÅ; Clinic for Cancer Treatment and Rehabilitation, Møre and Romsdal Hospital Trust, Ålesund, Norway., Gilje B; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway., Grønlie Cameron M; Department of Oncology, Sørlandet Hospital, Kristiansand, Norway., Hovland R; Department of Cancer Genomics, Haukeland University Hospital, Bergen, Norway., Falk RS; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway., Smeland S; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Giercksky Russnes HE; Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Department of Pathology, Oslo University Hospital, Oslo, Norway., Taskén K; Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Helland Å; Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo, Norway. aslaug.helland@medisin.uio.no.

Publikováno v: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2024 May 23; Vol. 63, pp. 379-384. Date of Electronic Publication: 2024 May 23.

DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables.

Autor: Kamalakaran S; Philips Research North America, Biomedical Informatics, Briarcliff Manor, NY 10510, United States. sitharthk@philips.com, Varadan V, Giercksky Russnes HE, Levy D, Kendall J, Janevski A, Riggs M, Banerjee N, Synnestvedt M, Schlichting E, Kåresen R, Shama Prasada K, Rotti H, Rao R, Rao L, Eric Tang MH, Satyamoorthy K, Lucito R, Wigler M, Dimitrova N, Naume B, Borresen-Dale AL, Hicks JB

Publikováno v: Molecular oncology [Mol Oncol] 2011 Feb; Vol. 5 (1), pp. 77-92. Date of Electronic Publication: 2010 Dec 02.

Methylation of WT1, CA10 in peripheral blood leukocyte is associated with breast cancer risk: a case-control study.

Autor: Ge, Anqi¹ (AUTHOR), Gao, Song² (AUTHOR), Liu, Yupeng¹ (AUTHOR), Zhang, Hui¹ (AUTHOR), Wang, Xuan¹ (AUTHOR), Zhang, Lei¹ (AUTHOR), Pang, Da² (AUTHOR) pangda@ems.hrbmu.edu.cn, Zhao, Yashuang¹ (AUTHOR) zhao_yashuang@263.net

Publikováno v: BMC Cancer. 7/31/2020, Vol. 20 Issue 1, p1-9. 9p. 5 Charts, 2 Graphs.

Modifications of H3K4 methylation levels are associated with DNA hypermethylation in acute myeloid leukemia.

Autor: Scalea, Stefania¹ (AUTHOR), Maresca, Carmen² (AUTHOR), Catalanotto, Caterina³ (AUTHOR), Marino, Rachele³ (AUTHOR), Cogoni, Carlo³ (AUTHOR), Reale, Anna¹ (AUTHOR), Zampieri, Michele¹ (AUTHOR), Zardo, Giuseppe¹ (AUTHOR) giuseppe.zardo@uniroma1.it

Publikováno v: FEBS Journal. Mar2020, Vol. 287 Issue 6, p1155-1175. 21p.

DNA methylation differences in noncoding regions in ER negative breast tumors between Black and White women DNA methylation differences in noncoding regions in ER negative breast tumors between Black and White women.

Autor: Jianhong Chen, Higgins, Michael J., Qiang Hu, Khoury, Thaer, Song Liu, Ambrosone, Christine B., Zhihong Gong

Publikováno v: Frontiers in Oncology; 2023, p1-11, 11p